Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

This study has been completed.
Information provided by:
Idera Pharmaceuticals, Inc. Identifier:
First received: August 1, 2008
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)